Factors Associated with HPV Vaccination in Young Males
- 566 Downloads
Human papilloma virus (HPV) affects both men and women; however, recommendations for HPV vaccination among men were not issued in the United States until 2011. The purpose of this study was to describe and compare characteristics of men who did and did not report receiving at least one dose of the HPV vaccine. Data from the ten states that completed the HPV vaccination module in the 2013 Behavioral Risk Factor Surveillance System (BRFSS) were included in the study. Young men ages 18–26 were included (N = 1624). Categorical variables were compared between those who did and did not receive the HPV vaccine using Chi square. Logistic regression was used to examine the odds of HPV vaccination by the above factors. Only 16.5% of men reported at least one dose of HPV vaccine. Having health insurance, having a primary doctor, and receiving an HIV test were predictive of HPV vaccination. Men in Texas were more likely to report HPV vaccination than all other states. Overall, HPV vaccination is low in men. Targeted interventions for improving HPV vaccination rates in men are warranted, especially for those without health insurance or a routine source of care.
KeywordsHPV vaccines Males BRFSS
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest to report.
- 1.Anderson, M., Dobkin, C., & Gross, T. (2012). The effect of health insurance coverage on the use of medical services. American Economic Journal: Economic Policy, 4(1), 1–27.Google Scholar
- 2.American Cancer Society. (2016). HPV vaccines: What is HPV? Retrieved from http://www.cancer.org/cancer/cancercauses/othercarcinogens/infectiousagents/hpv/hpv-faq.
- 3.Canepa, P., Orsi, M., Martini, M., & Icardi, G. (2013). HPV related diseases in males: A heavy vaccine-preventable burden. Journal of Preventative Medicine and Hygiene, 54(2), 61–70.Google Scholar
- 4.Centers for Disease Control and Prevention. (2016). Behavioral risk factor surveillance system. Retrieved January 4, 2017 from http://www.cdc.gov/brfss/.
- 5.Centers for Disease Control and Prevention. (2016). Genital HPV infection-fact sheet. Retrieved January 4, 2017 from http://www.cdc.gov/std/hpv/stdfact-hpv.htm.
- 6.Centers for Disease Control and Prevention. (2016). How many cancers are linked with HPV each year? Retrieved January 17, 2017 from http://www.cdc.gov/cancer/hpv/statistics/cases.htm.
- 7.Centers for Disease Control and Prevention. (2016). HPV and men-fact sheet. Retrieved January 18, 2017 from http://www.cdc.gov/std/hpv/stdfact-hpv-and-men.htm.
- 8.Centers for Disease Control and Prevention. (2016). Vaccines for children program. Retrieved February 1, 2017 from http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/.
- 9.Centers for Disease Control. (2016). Vaccines for children program. Retrieved February 2, 2017 from https://www.cdc.gov/vaccines/programs/vfc/about/index.html.
- 10.Centers for Disease Control and Prevention. (2015). Human papilloma virus: questions and answers. Retrieved February 7, 2017. http://www.cdc.gov/hpv/parents/questions-answers.html.
- 11.Cifu, A. S., & Davis, A. M. (2014). Use of HPV vaccine in males and females. JAMA, Clinical Guidelines Synopsis, 312(18), 1920–1921.Google Scholar
- 13.Gerend, M. A., Shepherd, M. A., Lustria, M. L., & Shepherd, J. E. (2016). Predictors of provider recommendation for HPV vaccine among young adult men and women: Findings from a cross sectional survey, Sexually Transmitted Infections, 92, 104–107. doi: 10.1136/sextrans-2015-052088.CrossRefPubMedGoogle Scholar
- 19.Markowitz, L. E., Dunne, E. F., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J., Bocchini, J. A., Unger, E. R. (2014). Human papillomavirus vaccination: Recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 63(RRO5), 1–30. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6305a1.htm.
- 20.Petrosky, E., Bocchini, J. J., Hariri, S., Chesson, H., Curtis, C. R., Saraiya, M., et al. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 64(11), 300–304.PubMedGoogle Scholar